NR1H4 and metabolic syndrome: Beneficial effects of C. mukul and its components on dyslipidemia may be due to the cholesterol synthesis inhibition in the liver by inhibition of the farnesoid X receptor (FXR) (Urizar et al., 2002 ▶).